- Home
- USEG vs ATNM Comparison
USEG vs ATNM Comparison
Compare USEG & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USEG | ATNM |
|---|---|---|
| Founded | 1966 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5M | 45.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | USEG | ATNM |
|---|---|---|
| Price | $1.01 | $1.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.2M | 115.7K |
| Earning Date | 03-12-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,484,000.00 | $90,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $57.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.11 |
| 52 Week Low | $0.91 | $1.03 |
| 52 Week High | $2.75 | $2.41 |
Technical Indicators
Market Signals| Indicator | USEG | ATNM |
|---|---|---|
| Relative Strength Index (RSI) | 48.99 | 33.16 |
| Support Level | $0.99 | $1.15 |
| Resistance Level | $1.09 | $1.20 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 23.08 | 6.24 |
Price Performance
Historical ComparisonAbout USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.